Skip to content
Screener

Medpace Holdings, Inc. MEDP Direct Costs — Labor and Related Expense

Similar metrics at other companies

PLB
PLBYDirect-to-Consumer — Labor and Related Expense
$4.71M+8.4%
Sunbelt Rentals Holdings logo
SUNBSpecialty — Labor and Related Expense
$185M+10.1%
Sunbelt Rentals Holdings logo
SUNBU.K. — Labor and Related Expense
$66M+4.8%
PLB
PLBYLicensing — Labor and Related Expense
$383K-35.5%
Labcorp Holdings logo
LHDiagnostics — Labor and Related Expense
$1.19B+5.7%
Raymond James Financial logo
RJFBank — Labor and Related Expense
$47M0.0%

Other financials

Income statement

See full
Revenue$707.3M+17.2%
Operating income$146.8M+16.2%
Net income$121.4M+34.5%
EPS (diluted)$4.25+37.1%

Balance sheet

See full
Cash & equivalents$502.7M+985%
Total debt$144.1M-3.8%
Total equity$433.9M+152%
Total assets$2.1B+30.9%

Cash flow

See full
Operating cash flow$162.0M+9.1%
CapEx$23.9M+291%
Free cash flow$138.1M-3.0%

Valuation

See full
Market cap$16.41B+35.7%
Enterprise value$16.05B+31.6%
P/E33.4×+4.5×
P/S5.9×+0.5×

Profitability

See full
Operating margin21%-0.4pp
Net margin17.7%-1.1pp
FCF margin25.4%-0.6pp

Returns & leverage

See full
Return on equity162.2%+72.8pp
Debt / equity0.3×-0.5×
Current ratio0.7×+0.3×

Where this comes from

Reported directly by Medpace Holdings, Inc. in its filing.

Tagged under the XBRL concept us-gaap:LaborAndRelatedExpense.

The source filing: Medpace Holdings, Inc.’s 10-Q, filed July 23, 2026.

Filed
Jul 23, 2026, 4:03 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001668397-26-000025
Line itemThree Months Ended June 30, 2026Three Months Ended June 30, 2025Six Months Ended June 30, 2026Six Months Ended June 30, 2025
Revenue, net$707,331$603,311$1,413,935$1,161,881
Operating expenses:
Direct service costs, excluding depreciation and amortization - Employee compensation163,089147,942327,692291,869
Direct service costs, excluding depreciation and amortization - Other segment items (a)39,46637,88473,13771,773
Reimbursed out-of-pocket expenses303,139237,472615,143439,876
Total direct costs505,694423,2981,015,972803,518
Selling, general and administrative48,10346,66496,020104,561
Depreciation6,5556,77713,30613,471

Item 1. Financial Statements (unaudited)

FAQ

What is Medpace Holdings, Inc.'s direct costs — labor and related expense?
Medpace Holdings, Inc. (MEDP) reported direct costs — labor and related expense of $163.09M in Q2 2026.
How has Medpace Holdings, Inc.'s direct costs — labor and related expense changed year-over-year?
Medpace Holdings, Inc.'s direct costs — labor and related expense increased by 10.2% year-over-year, from $147.94M to $163.09M.
What is the long-term trend for Medpace Holdings, Inc.'s direct costs — labor and related expense?
Over 3 years (2022 to 2025), Medpace Holdings, Inc.'s direct costs — labor and related expense has grown at a 12.8% compound annual growth rate (CAGR), from $410.51M to $588.79M.
What does direct costs — labor and related expense mean?
This metric captures the compensation, benefits, and associated payroll costs for employees directly involved in clinical trial execution and project management. As a human-capital-intensive business, these costs represent the largest component of the company's service delivery expenses. Tracking this allows investors to assess the company's ability to manage its primary resource—skilled clinical research personnel—against project demand.

Ask your AI about Medpace Holdings, Inc.'s direct costs — labor and related expense.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude